BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26560951)

  • 1. [Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].
    Mori M
    Brain Nerve; 2015 Nov; 67(11):1359-69. PubMed ID: 26560951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathology of the Peripheral Nervous System in Guillain-Barré Syndrome].
    Nakano Y; Kanda T
    Brain Nerve; 2015 Nov; 67(11):1329-39. PubMed ID: 26560948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome.
    Arcila-Londono X; Lewis RA
    Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome.
    Sawai S; Satoh M; Mori M; Misawa S; Sogawa K; Kazami T; Ishibashi M; Beppu M; Shibuya K; Ishige T; Sekiguchi Y; Noda K; Sato K; Matsushita K; Kodera Y; Nomura F; Kuwabara S
    Neurology; 2014 Jul; 83(2):113-7. PubMed ID: 24920858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome.
    Hughes RA; Cornblath DR
    Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies.
    Yu RK; Ariga T; Usuki S; Kaida K
    Adv Exp Med Biol; 2011; 705():349-65. PubMed ID: 21618117
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
    Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
    Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Guillain-Barré syndrome.
    Fujimura H
    Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
    Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
    Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan.
    Nagasawa K; Kuwabara S; Misawa S; Fujii K; Tanabe Y; Yuki N; Hattori T; Kohno Y
    Muscle Nerve; 2006 Jun; 33(6):766-70. PubMed ID: 16506153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guillain Barré syndrome in pediatrics].
    Erazo Torricelli R
    Medicina (B Aires); 2009; 69(1 Pt 1):84-91. PubMed ID: 19240005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
    Kuwabara S; Ogawara K; Sung JY; Mori M; Kanai K; Hattori T; Yuki N; Lin CS; Burke D; Bostock H
    Ann Neurol; 2002 Aug; 52(2):180-7. PubMed ID: 12210788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barre syndrome and its frontiers].
    Azulay JP; Verschueren A; Attarian S; Pouget J
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré Syndrome.
    Kaida K
    Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic relevance of α
    Dong C; Palladino SP; Helton ES; Ubogu EE
    Acta Neuropathol; 2016 Nov; 132(5):739-752. PubMed ID: 27460017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
    Ho TW; Willison HJ; Nachamkin I; Li CY; Veitch J; Ung H; Wang GR; Liu RC; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
    Ann Neurol; 1999 Feb; 45(2):168-73. PubMed ID: 9989618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome occurring in two women after ketoacidosic comatose state disclosing an insulin-dependent diabetes mellitus.
    Rouanet-Larriviere M; Vital C; Arne P; Favarel-Garrigues JC; Gin H; Vital A
    J Peripher Nerv Syst; 2000 Mar; 5(1):27-31. PubMed ID: 10780681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.